How AI Search Is Recommending Online Pharmacies

Patient discovery of online pharmacies is shifting from search engine results and brand recognition to AI-generated recommendations. When patients ask an AI assistant which online pharmacy to use, they increasingly receive ranked shortlists with justifications, not directory listings. This changes where patient consideration is formed and which brands capture the decision moment, before the patient ever visits a website or compares prices directly.

The LLM Authority Index benchmark for August 2026 reveals a market where Amazon Pharmacy has established clear AI recommendation leadership, while traditional pharmacy chains like Walgreens and CVS Pharmacy appear frequently but convert that visibility into recommendation credit poorly. CiteWorks Studio interprets this benchmark to show which brands are winning recommendation-stage visibility, which are merely present, and what the evidence suggests about the public sources shaping AI answers in this category.

Methodology

1. Market studied: Online pharmacies, including retail pharmacy chains, mail-order prescription services, digital pharmacy platforms, and pharmacy benefit managers with consumer-facing services operating in the United States.

2. Brands and entities included: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx, Honeybee Health, Optum Rx, PillPack (operating within the Amazon Pharmacy ecosystem), and Walgreens. This universe covers major players in the category but is not exhaustive. Smaller regional pharmacies and emerging entrants were not included in this benchmark cycle.

3. Data collection date and window: Data was extracted on August 1, 2026, for the August 2026 reporting month. This represents a single-cycle point-in-time snapshot.

4. AI platforms tested: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.

5. Number of prompts tested: 800 total prompts were tested across all platforms. 596 prompts were eligible for analysis after filtering. The prompt count was provided in the source data; all observations were analyzed across eligible prompts.

6. Prompt categories: The dataset covers consideration-stage prompts, including discovery and evaluation queries such as "Which is the most reliable online pharmacy?", "What are the top 5 pharmacies?", and "What is the best online prescription website?" The full LLM Authority Index report includes comparison, pricing, decision, and purchase-stage prompt clusters. This public interpretation focuses on the consideration layer.

7. Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment, framing, ranking position, or whether the brand was recommended. Mention presence alone does not constitute recommendation credit.

8. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality recommendation or ranked recommendation that earns recommendation credit in the scoring methodology. Neutral mentions, cautionary references, comparison anchors, and list appearances without positive framing are not counted as valid recommendations. This distinction is the foundation of the CiteWorks interpretation: visibility is not the same as recommendation credit.

9. Ranking and scoring metrics used: Raw mention presence rate, positive visibility rate, neutral visibility rate, negative visibility rate, net sentiment score, valid recommendation coverage rate, top-three rate, rank-one rate, top-ten rate, and average recommended rank. Monetary benchmark metrics from the source data are omitted from this public version of the analysis.

10. Limitations: This is a point-in-time benchmark based on AI outputs captured in August 2026. AI outputs change as models are updated, retrained, and as public source material evolves. Monetary metrics from the source dataset are not published in this analysis. This report is not a full audit, full competitive census, or predictive model. Modeled values where referenced are benchmark estimates and are not revenue, pipeline, or booked demand. The prompt universe covers consideration-stage queries and may not fully represent all buyer stages or all AI platform behaviors.

Key Findings

Amazon Pharmacy leads the category in recommendation strength, not just visibility. The benchmark shows Amazon Pharmacy achieved a 38.3% valid recommendation coverage rate across 596 eligible observations from six AI platforms in August 2026, meaning it earned positive shortlist-quality recommendations in more than one in three prompts tested. Its 25.8% top-three rate and 17.3% rank-one rate were the highest recorded in the category. Its average recommended rank of 1.79 confirms that when Amazon Pharmacy appears in ranked AI responses, it consistently appears near the top of the list. This is a recommendation-strength profile, not merely a visibility profile.

Traditional pharmacy chains show a pronounced visibility-to-recommendation gap. Walgreens appeared in 82.4% of AI responses and CVS Pharmacy in 82.5%, the two highest presence rates in the category. Yet both converted that presence into valid recommendations at only a 22.3% rate. Walgreens achieved a 1.0% rank-one rate, meaning it was advanced to the first recommendation position in fewer than one in one hundred AI responses. CVS Pharmacy achieved a 3.5% rank-one rate. The analysis found that these brands are being mentioned but not advanced, a pattern suggesting AI systems recognize their relevance without prioritizing them as preferred choices.

GoodRx is the strongest challenger, converting presence into recommendation credit efficiently. GoodRx's raw mention presence rate of 68.1% trailed Amazon Pharmacy's 80.0%, but its 29.7% valid recommendation coverage placed it second in recommendation power across the category. Its 11.4% top-three rate and 4.5% rank-one rate indicate consistent shortlist positioning. Its net sentiment score of 0.58 reflects that AI systems frame GoodRx positively when they mention it, giving it an advantage that extends beyond price-comparison recognition into general pharmacy recommendation territory.

Cost Plus Drugs demonstrates strong recommendation quality relative to its presence. The benchmark found Cost Plus Drugs achieved a 26.3% valid recommendation coverage rate from a 45.8% presence rate, showing efficient conversion. Its 13.9% top-three rate was competitive with CVS Pharmacy despite lower overall presence. Its net sentiment score of 0.75 was the highest among the major measured brands, indicating that AI systems frame it favorably when they surface it. The constraint for Cost Plus Drugs is presence volume, not framing quality.

Recommendation concentration is compressing the category into a narrow shortlist. Amazon Pharmacy and GoodRx captured the majority of top-three and rank-one positions across all tested prompts. Brands including Optum Rx, Capsule, and Honeybee Health showed limited presence and minimal top-three or rank-one appearances. Optum Rx achieved a 0.0% rank-one rate, meaning it was never the first recommendation in any measured AI response. This concentration pattern means that brands outside the top two are largely competing for secondary list positions rather than leading recommendations.

What Changed in the Market

Patient discovery of online pharmacies is no longer determined only by search engine results, television advertising, or proximity to a physical location. Patients are asking AI systems to compare providers, explain reliability, summarize pricing structures, surface alternatives, and recommend shortlists. This behavioral shift moves the competitive battleground from traditional brand recognition to recommendation-stage visibility, where AI systems rank and frame brands in ways that directly shape patient consideration before any direct brand interaction occurs.

The structure of AI responses differs meaningfully from search engine results. A search result page presents options in parallel; the patient decides what to click. An AI-generated recommendation presents a ranked opinion, often with justification, that positions one brand as the better choice and others as secondary options. This framing effect is commercially significant in a category where patients are making decisions about prescription access, cost, convenience, and trust. Being third on an AI shortlist is not the same as being third in a search result set.

The trust dimension of this category makes framing quality particularly important. Patients are asking AI systems not only which pharmacy is cheapest but which is most reliable, most legitimate, and safest. The evidence suggests that brands with stronger public validation, clearer service explanations, and more consistent third-party coverage are better positioned to earn positive framing in these trust-oriented responses. Amazon Pharmacy's 52.4% positive visibility rate reflects that AI systems consistently frame it in favorable terms, while CVS Pharmacy's 0.33 net sentiment score reflects more mixed framing despite equivalent presence.

Recommendation concentration matters because patient attention is not evenly distributed across an AI response. The brands that appear in the first one or two positions receive the majority of consideration. When Amazon Pharmacy appears as the first recommendation in 17.3% of all AI responses and GoodRx appears in the top three in 11.4%, these brands are consistently intercepting patient attention at the decision moment. Traditional pharmacy chains that appear later in the list, or that appear in neutral rather than recommended framing, are not capturing the same level of consideration even when they are present in the response.

What the Benchmark Found

Recommendation leader: Amazon Pharmacy leads the category with the strongest recommendation profile across all measured platforms. Its 38.3% valid recommendation coverage rate is the highest in the market. Its 17.3% rank-one rate means it is the first recommendation in nearly one in five AI responses. Its average recommended rank of 1.79 confirms consistent top-of-list positioning. Its 52.4% positive visibility rate indicates that AI systems frame it favorably in the majority of mentions. Amazon Pharmacy's recommendation profile reflects both presence strength and framing quality operating together.

Strongest challenger: GoodRx demonstrates the strongest challenger pattern in the category. Its 68.1% presence rate is lower than Amazon Pharmacy's 80.0%, but its 29.7% valid recommendation coverage places it clearly second in recommendation power. GoodRx achieves an 11.4% top-three rate and a 4.5% rank-one rate. Its net sentiment score of 0.58 reflects consistently positive framing. The evidence suggests GoodRx benefits from strong presence in cost-related and comparison-oriented prompt clusters, giving it a recommendation footprint that extends beyond its core pricing tool identity.

Visible but under-recommended: CVS Pharmacy presents the most visible underperformer profile in the category. Its 82.5% presence rate is the highest among all measured brands, yet its 22.3% valid recommendation coverage reveals a significant conversion gap. CVS achieves a 12.6% top-three rate and a 3.5% rank-one rate. Its net sentiment score of 0.33 is the lowest among major brands, indicating that AI systems frame it in more neutral or mixed terms relative to competitors. High presence without recommendation conversion means CVS is contributing to AI responses without capturing the commercial benefit of those appearances.

Visible but not advanced: Walgreens shows the most pronounced presence-to-recommendation gap in the category. Its 82.4% presence rate nearly matches CVS Pharmacy, but its 22.3% valid recommendation coverage rate, 9.1% top-three rate, and 1.0% rank-one rate indicate that AI systems almost never advance Walgreens to the leading recommendation position. Its net sentiment score of 0.34 reflects neutral framing that does not generate recommendation credit. The data pattern suggests Walgreens is consistently present in AI responses as a recognized brand without earning the positive advancement that drives shortlist consideration.

Mid-tier with positive framing: Express Scripts shows a moderate recommendation profile with notably strong sentiment signals. Its 33.9% presence rate and 16.8% valid recommendation coverage rate place it in the mid-tier. Express Scripts achieves a 7.7% top-three rate and a 1.9% rank-one rate. Its net sentiment score of 0.69 is among the highest in the category, indicating that when AI systems surface Express Scripts, they tend to frame it positively. The gap between its sentiment quality and its top-three rate suggests a presence volume constraint rather than a framing quality problem.

Strong recommendation quality, limited presence: Cost Plus Drugs demonstrates efficient recommendation conversion relative to its presence. Its 45.8% presence rate and 26.3% valid recommendation coverage rate reflect a brand that earns strong credit when it appears. Its 13.9% top-three rate is competitive with CVS Pharmacy despite lower overall presence. Its 4.0% rank-one rate and 0.75 net sentiment score, the highest among major brands, indicate that AI systems frame it consistently and favorably. Cost Plus Drugs' primary constraint is the volume of prompts in which it appears, not the quality of its recommendation framing.

Present but not prioritized: Optum Rx shows moderate presence with limited recommendation conversion. Its 25.3% presence rate and 13.1% valid recommendation coverage rate place it in the lower mid-tier. Critically, Optum Rx achieves a 0.0% rank-one rate, meaning it was not the first recommendation in any measured AI response across 596 eligible observations. Its average recommended rank of 3.98 indicates that when it does receive recommendation credit, it appears toward the bottom of shortlists. This positioning suggests AI systems recognize Optum Rx as a legitimate option without treating it as a preferred choice.

Specialist option within the Amazon ecosystem: PillPack functions as a specialized recommendation asset with a narrow but high-quality presence profile. Its 11.2% presence rate and 10.2% valid recommendation coverage rate are modest in absolute terms, but its 97.0% net sentiment score is the highest in the category. PillPack achieves a 6.4% top-three rate and a 2.4% rank-one rate, indicating strong recommendation quality when surfaced. The evidence suggests AI systems recommend PillPack in specific use-case contexts, particularly medication management and adherence, rather than as a general pharmacy option.

Positive framing, limited reach: Capsule shows limited presence with moderate recommendation quality. Its 11.4% presence rate and 7.4% valid recommendation coverage rate place it in the lower tier. Capsule achieves a 3.2% top-three rate and a 0.8% rank-one rate. Its net sentiment score of 0.81 is strong, indicating favorable framing when AI systems do surface it. The source pattern may indicate that Capsule's public evidence layer is not yet broad enough to generate consistent mention presence across a wide range of prompts.

Weakest recommendation profile: Honeybee Health shows the weakest overall recommendation profile among measured brands. Its 10.1% presence rate and 6.7% valid recommendation coverage rate are the lowest in the category. Honeybee Health achieves a 2.0% top-three rate and a 0.2% rank-one rate. Its net sentiment score of 0.83 is strong, suggesting favorable framing when it does appear. The evidence suggests the constraint is limited public evidence layer depth rather than framing quality, as the brand converts well when present but simply does not appear across enough prompts to build meaningful recommendation volume.

Why Visibility Is Not Enough

A brand can appear in AI answers and still fail to win the patient shortlist. The online pharmacy category makes this distinction concrete. Walgreens and CVS Pharmacy appear in more than 82% of AI responses, the two highest presence rates in the measured universe. Yet both convert that presence into valid recommendations at only 22.3%. They are named in nearly every relevant AI response. They are chosen as top recommendations in very few.

Raw mention presence and valid recommendation coverage measure different things. Presence measures how often a company appears in an AI-generated response in any form. Valid recommendation coverage measures how often that appearance is a positive, shortlist-quality recommendation that earns recommendation credit. A brand can appear in a neutral market overview, a comparison table, a historical reference, or a cautionary note and generate a mention without generating a recommendation. The distinction matters commercially because patients respond to recommendations, not to appearances.

Top-three placement concentrates commercial value further. The brands appearing in the first three positions of an AI response receive the majority of patient consideration. Amazon Pharmacy's 25.8% top-three rate means it appears in the most influential positions far more often than any competitor. Rank-one placement is even more concentrated: Amazon Pharmacy leads 17.3% of AI responses in this category while Walgreens leads 1.0%. These are not marginal differences in positioning. They reflect a significant gap in where brand consideration is captured.

Framing quality separates brands that earn recommendation credit from brands that earn only acknowledgment. Amazon Pharmacy, GoodRx, Cost Plus Drugs, and PillPack are framed positively when mentioned. CVS Pharmacy and Walgreens carry net sentiment scores of 0.33 and 0.34, the lowest among major brands, indicating that AI systems frame them in more neutral or mixed terms. Neutral framing does not generate recommendation credit. A brand can be described accurately and even favorably in general terms without being advanced as the recommended choice.

Citation frequency is also not endorsement. A brand can be cited consistently in factual contexts, market overviews, general discussions, and comparison tables without earning a recommendation. The benchmark evidence suggests AI systems acknowledge the relevance of traditional pharmacy chains as recognized market participants without prioritizing them as the preferred patient recommendation. Being named by AI is not the same as being chosen by AI, and the commercial consequences of that distinction accumulate over time.

The Citation Layer

AI systems rely on retrievable, citable public sources to construct their responses. Brands with stronger, more consistent public evidence layers give AI systems more material to work with when forming recommendations. The benchmark evidence suggests the following source patterns are relevant to the online pharmacy category, though the precise causal relationship between specific sources and specific AI outputs cannot be confirmed from this dataset alone.

Official brand sites appear to be part of the public evidence layer for all major brands in the category. Amazon Pharmacy benefits from extensive official content describing its service model, pricing structure, Prime integration, and delivery options. This content gives AI systems retrievable material to synthesize into confident recommendation narratives. Traditional pharmacy chains have substantial official sites, but the benchmark evidence suggests official site presence alone does not translate into recommendation strength when framing quality and third-party validation are weaker.

Price-comparison platforms appear to shape cost-related and value-oriented AI responses. GoodRx generates consistent, citable content through its core comparison platform, giving AI systems retrievable source material for cost-related prompts. This source visibility gives GoodRx a recommendation footprint that extends beyond its brand recognition into prompts asking about affordability, prescription savings, and value. The source pattern may indicate that GoodRx's comparison content functions as a durable citation source across multiple prompt types.

Comparison articles and editorial reviews appear to support recommendation narratives in this category. Brands that appear consistently and favorably in comparison content give AI systems more material to synthesize when constructing ranked lists. The evidence suggests Amazon Pharmacy and GoodRx benefit from broader comparison-site presence, contributing to their stronger recommendation profiles. Brands that are frequently compared but not frequently preferred may be contributing to the visibility of competitors even when their own brand appears.

Review platforms and community discussions may be part of the public evidence layer for trust-oriented prompts. The online pharmacy category is trust-sensitive; patients asking AI systems which pharmacy is most reliable are implicitly asking which has the strongest evidence of quality, safety, and service. Brands with more consistent positive review coverage and broader community discussion presence may give AI systems more retrievable evidence to support confident recommendations. The source pattern may explain why brands with strong official positioning but mixed review environments struggle to convert presence into recommendation credit.

Search-visible pages and backlink-supported content remain relevant as supporting evidence for the traditional source layer. Brands with stronger organic search footprints and well-ranking pages give AI systems more search-visible material that may be retrievable or synthesizable. However, search visibility alone does not determine AI recommendation influence. The benchmark evidence controls the AI recommendation story. Ahrefs-type signals are supporting evidence for the source footprint, not proof of AI recommendation outcomes.

The citation layer explanation offered here is interpretive. The benchmark shows which brands are recommended and how they are framed. It does not prove which specific sources caused those outputs. The evidence suggests that brands with stronger, more consistent public evidence layers are better positioned to earn recommendation credit, and that brands with thin, fragmented, or inconsistent evidence layers are more likely to appear without being advanced.

What Brands Need to Fix

Weak valid recommendation coverage. Brands like Walgreens and CVS Pharmacy need to close the gap between presence and recommendation credit. Appearing in AI responses is not the strategic goal. Earning positive shortlist-quality recommendations is. The benchmark evidence suggests these brands have recognition without the framing quality or source support needed to convert that recognition into recommendations.

Low top-three and rank-one presence. Walgreens achieves a 1.0% rank-one rate and a 9.1% top-three rate. Optum Rx achieves a 0.0% rank-one rate. These brands need to understand which prompt clusters, source types, and framing conditions could help them move from general mentions into top-list positions. The brands currently leading the top-three and rank-one positions are not simply more recognized; they are better supported by the kind of evidence AI systems use to justify leading recommendations.

Neutral or mixed framing. CVS Pharmacy and Walgreens carry the lowest net sentiment scores in the category at 0.33 and 0.34. Improving framing quality requires understanding which public sources and content types are contributing to the current framing pattern and which adjustments could shift AI systems toward more consistently positive characterization.

Thin source footprint for smaller brands. Capsule and Honeybee Health show strong framing when they appear but limited presence across prompts. Their positive sentiment scores suggest the quality of framing is not the problem. The constraint is breadth of retrievable public evidence. Building a wider, more consistent citation architecture could help these brands appear in more prompts and earn recommendation credit more frequently.

Weak third-party validation. The evidence suggests that brands with stronger editorial coverage, review platform presence, and comparison-site appearances are recommended more confidently by AI systems. Brands that rely primarily on official owned content without strong third-party validation may find AI systems unwilling to advance them as preferred choices.

Underdeveloped content for trust-oriented and use-case-specific prompts. The online pharmacy category includes prompts about reliability, safety, cost, delivery, specialty medications, and patient experience. Brands that lack clear, retrievable content addressing these specific use cases may be absent from or weakly represented in the corresponding prompt clusters.

Fragmented or inconsistent entity information. Brands that appear differently across source types, with inconsistent service descriptions, pricing information, or category positioning, may give AI systems conflicting signals. Consistent entity information across all public surfaces strengthens the retrievability and confidence of AI recommendations.

How CiteWorks Studio Helps

1. Map AI recommendation visibility. Track prompts, platforms, company presence, valid recommendations, top-three and rank-one performance, framing, and citation sources across the relevant prompt clusters in your category.

2. Identify the sources shaping AI answers. Find the editorial, review, forum, government, directory, owned, search-visible, and backlink-supported sources that influence brand framing and recommendation credit in AI-generated responses.

3. Build the citation architecture plan. Strengthen the public evidence layer so AI systems have more accurate, consistent, and persuasive source material to synthesize when forming recommendations in your category.

Commercial Takeaway

AI-led discovery is changing where patient shortlists are formed in the online pharmacy category. When patients ask AI systems which online pharmacy to use, they receive ranked recommendations that consistently favor Amazon Pharmacy and GoodRx. Traditional pharmacy chains appear in these responses but are positioned as secondary options despite their dominant brand presence. Over time, this pattern shapes patient perception and selection in ways that do not require the patient to evaluate the brands directly. The recommendation happens before the patient comparison begins.

Brands can lose recommendation-stage visibility even while maintaining high mention rates. Walgreens and CVS Pharmacy appear in more than 82% of AI responses yet convert that presence into valid recommendations at only a 22.3% rate. Competitors are intercepting demand in high-intent prompt clusters where patients are asking which pharmacy to use, which is most reliable, and which offers the best value. The brands winning those prompts are not simply more recognized. They are better supported by the kind of public evidence AI systems use to justify leading recommendations.

The opportunity in this category is to improve recommendation-stage visibility, not merely to chase mentions. Traditional search and source visibility still matter because they contribute to the public evidence layer that AI systems draw from. Brands that build consistent, retrievable, and credible citation architecture across editorial, review, comparison, and owned content surfaces will be better positioned to earn recommendation credit at the decision moment. The benchmark identifies where that gap currently exists and which brands are already capturing the shortlist.

See Where Competitors Are Being Recommended Instead

The benchmark evidence shows where online pharmacy brands appear in AI responses, which brands are earning top-three and rank-one recommendation credit, and which prompts carry the most commercial risk for brands currently visible but under-recommended. CiteWorks Studio can show where your brand appears across AI platforms, which sources appear to be shaping your framing, where competitors are being recommended instead of you, and what needs to change to improve your recommendation-stage visibility. Request an AI Visibility Audit, AI Market Discovery Profile, or Citation Architecture Review to understand your brand's position in the AI recommendation landscape for this category.

Benchmark Source

This analysis is based on the 2026 AI Discovery Index for Online Pharmacies, published by LLM Authority Index. Read the full benchmark report at the LLM Authority Index website.